EPISODE · Aug 2, 2021 · 13 MIN
Safety of JAK Inhibitors
from HCPLive Podcasts · host HCPLive.com
Roy Fleischmann, MD, discusses the recent Pfizer press release touching upon the safety of JAK inhibitors. He explains the recent scrutiny of JAKs, the concerns some rheumatologists have in regard to JAK inhibitors, and his personal opinions on prescribing JAK inhibiting drugs to his patients.
Embed this episode
NOW PLAYING
Safety of JAK Inhibitors
0:00
13:07
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of HCPLive Podcasts?
This episode is 13 minutes long.
When was this HCPLive Podcasts episode published?
This episode was published on August 2, 2021.
Can I download this HCPLive Podcasts episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!